Adding Immunotherapy to Neurofibromatosis Treatment May Mitigate Hearing Loss – Specialty Pharmacy Times
|
Adding Immunotherapy to Neurofibromatosis Treatment May Mitigate Hearing Loss
Specialty Pharmacy Times The addition of an immunotherapy may prevent serious hearing damage related to radiotherapy that treats tumors associated with neurofibromatosis 2 (NF2), according to a study published by PNAS Plus. The researchers found that crizotinib inhibited a … |
